CUTRUPI, SEBASTIANO

CUTRUPI, SEBASTIANO  

Istituto di Fisiologia Clinica - IFC - Sede Secondaria di Reggio Calabria  

Mostra records
Risultati 1 - 20 di 96 (tempo di esecuzione: 0.05 secondi).
Titolo Data di pubblicazione Autore(i) File
Osteopontin, death and cardiovascular events in stage G3–4 CKD patients: a joint model analysis 1-gen-2024 D' Arrigo, Graziella; Carbone, Federico; Gori, Mercedes; Torino, Claudia; Montecucco, Fabrizio; Liberale, Luca; Ramoni, Davide; Tirandi, Amedeo; Tortorella, Curzia; Lisa, Anna; Olivero, Chiara; Moriero, Margherita; Bertolotto, Maria; Minetti, Silvia; Schiavetta, Elisa; Pizzini, Patrizia; Cutrupi, Sebastiano; Mallamaci, Francesca; Tripepi, Giovanni; Zoccali, Carmine
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass 1-gen-2024 Serraino, Giuseppe Filiberto; Bolignano, Davide; Jiritano, Federica; Coppolino, Giuseppe; Napolitano, Désirée; Zicarelli, Mariateresa; Pizzini, Patrizia; Cutrupi, Sebastiano; Testa, Alessandra; Spoto, Belinda; Andreucci, Michele; Mastroroberto, Pasquale; Serra, Raffaele
Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy 1-gen-2023 Politi, Cristina; Mobrici, Marco; Parlongo, ROSA MARIA TERESA; Spoto, Belinda; Tripepi, Giovanni; Pizzini, Patrizia; Cutrupi, Sebastiano; Franco, Daniele; Tino, Renato; Farruggio, Giuseppe; Failla, Chiara; Marino, Flavia; Pioggia, Giovanni; Testa, Alessandra
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 1-gen-2022 Bolignano, Davide; Jiritano, Federica; Zicarelli, Mariateresa; Pizzini, Patrizia; Cutrupi, Sebastiano; Andreucci, Michele; Testa, Alessandra; Battaglia, Domenica; Spoto, Belinda; Mastroroberto, Pasquale; Serraino, Giuseppe Filiberto; Coppolino, Giuseppe
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 1-gen-2021 Panuccio, V; Mallamaci, F; Pizzini, P; Tripepi, R; Garofalo, C; Parlongo, G; Caridi, G; Provenzano, M; Mafrica, A; Simone, G; Cutrupi, S; D'Arrigo, G; Porto, G; Tripepi, G; Nardellotto, A; Meneghel, G; Dattolo, P; Pizzarelli, F; Rapisarda, F; Ricchiuto, A; Fatuzzo, P; Verdesca, S; Gallieni, M; Gesualdo, L; Conte, G; Plebani, M; Zoccali, C
FGF23 and the PTH response to paricalcitol in chronic kidney disease 1-gen-2020 D'Arrigo, Graziella; Pizzini, Patrizia; Cutrupi, Sebastiano; Tripepi, Rocco; Tripepi, GIOVANNI LUIGI; Mallamaci, Francesca; Zoccali, Carmine
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 1-gen-2019 Spoto, BELINDA GILDA; Kakkar, Rahul; Lo, Larry; Devalaraja, Matt; Pizzini, Patrizia; Torino, Claudia; Leonardis, Daniela; Cutrupi, Sebastiano; Tripepi, GIOVANNI LUIGI; Mallamaci, Francesca; Zoccali, Carmine
Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial 1-gen-2019 D'Arrigo, G; Pizzini, P; Cutrupi, S; Tripepi, R; Tripepi, G; Mallamaci, F; Zoccali, C
Intact FGF23 and -klotho during acute inflammation/sepsis in CKD patients 1-gen-2017 Dounousi, Evangelia; Torino, Claudia; Pizzini, Patrizia; Cutrupi, Sebastiano; Panuccio, Vincenzo; D'Arrigo, Graziella; Abd ElHafeez, Samar; Tripepi, GIOVANNI LUIGI; Mallamaci, Francesca; Zoccali, Carmine
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients 1-gen-2016 Dounousi E.; Torino C.; Pizzini P.; Cutrupi S.; Panuccio V.; D'Arrigo G.; Abd ElHafeez S.; Tripepi G.; Mallamaci F.; Zoccali C.
Intact FGF23 and ?-klotho during acute inflammation/sepsis in CKD patients 1-gen-2016 Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C
Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients 1-gen-2016 Zoccali, C.; Torino, C.; Curatola, G.; Panuccio, V.; Tripepi, R.; Pizzini, P.; Versace, M.; Bolignano, D.; Cutrupi, S.; Ghiadoni, L.; Thadhani, R.; Tripepi, G.; Mallamaci, F.
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 1-gen-2014 Spoto, B; Di Betta, E; Mattaceraso, F; Sijbrands, E; Vilardi, A; Parlongo, Rm; Pizzini, P; Pisano, A; Vermi, W; Testa, A; Cutrupi, S; D'Arrigo, G; Lonardi, S; Tripepi, G; Cancarini, G; Zoccali, C
Resistin and all-cause and cardiovascular mortality: Effect modification by adiponectin in end-stage kidney disease patients 1-gen-2013 Spoto B.; MattaceRaso F.; Sijbrands E.; Pizzini P.; Cutrupi S.; D'Arrigo G.; Tripepi G.; Zoccali C.; Mallamaci F.
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD) 1-gen-2012 Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; Tripepi, R; Tripepi, G; De Caterina, R
INDICES OF INSULIN RESISTANCE AND RISK OF TOTAL AND CARDIOVASCULAR MORTALITY IN DIALYSIS PATIENTS 1-gen-2012 Postorino, Maurizio; Cutrupi, Sebastiano; Pizzini, Patrizia; Marino, Carmela; D'Arrigo, Graziella; Tripepi, GIOVANNI LUIGI; Zoccali, Carmine
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 1-gen-2012 Spoto, B; Leonardis, D; Parlongo, Rm; Pizzini, P; Pisano, A; Cutrupi, S; Testa, A; Tripepi, G; Zoccali, C; Mallamaci, F
Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD). 1-gen-2012 Tripepi G; MattaceRaso F; Pizzini P; Cutrupi S; Witteman J; Zoccali C; Mallamaci F. Tripepi G.; MattaceRaso F.; Pizzini P.; Cutrupi S.; J.Witteman; C.Zoccali; F.Mallamaci.
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients 1-gen-2011 Zoccali, C; Postorino, M; Marino, C; Pizzini, P; Cutrupi, S; Tripepi, G
C-Reactive Protein and Interleukin-6 modify the risk of high levels of Asymmetric Dimethyl-Arginine (ADMA) for death and cardiovascular events in end stage renal diseases patients. 1-gen-2010 Tripepi G.; Boeger R.; R.Maas R.; Pizzini P.; Cutrupi S.; Zoccali C.